Oxycodoni hydrochloridum, Naloxoni hydrochloridum
| Medicinal product name | Geroxynal 5 mg/2.5 mg prolonged-release tablets |
||||||
|---|---|---|---|---|---|---|---|
| Pharmaceutical form | Prolonged-release tablet | ||||||
| Strength | 5 mg/2.5 mg | ||||||
| Information from the MAH on shortages |
Not available predicted availability date: not notified |
||||||
| Availability of medicinal product |
|
||||||
| Legal status | Prescription (Pr.I) | ||||||
| Package leaflet |  06-06-2023
|
||||||
| Summary of product characteristics | 06-06-2023
|
||||||
| ATC code | N02AA55 – Analgesics | ||||||
| Information for Marketing authorisation holders | View |
Medicinal products (11)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N7 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-01 |
 Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-02 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-03 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-04 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-05 |
Labelling text Sep 27, 2018 |
|
|
Is available (according to the information provided by wholesalers) (900 containers) predicted availability date: Oct 2, 2023 |
Tamro |
N30 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-06 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-07 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-08 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-09 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N98 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-10 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (5 mg/2,5 mg) |
PVC/PVDC/Al blister | 17-0233-11 |
Labelling text Sep 27, 2018 |
Registration information
| Marketing authorisation No. | 17-0233 |
|---|---|
| Date of authorisation | Oct 25, 2017 |
| Marketing authorisation holder, country | G.L. Pharma GmbH, Austria |
